drugset / Trial / NCT01341964

Clopidogrel and Aspirin Interaction Study-2

NCT01341964 ↗

Phase 4 Completed 302 enrolled Population Health Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Clopidogrel and aspirin are commonly used in combination to prevent heart attacks and to prevent blockage of stents. Both clopidogrel and aspirin work by preventing platelets (sticky cells that circulate in the blood) from forming blood clots in the arteries supplying oxygen to the heart and in stents. The investigators hypothesize that aspirin 325mg compared with aspirin 81 mg will increase blood levels of the active metabolite of clopidogrel in patients with a history of coronary artery disease who receive a 600mg loading dose of clopidogrel.

Timeline

Start
2011-05
Primary completion
2013-04
Completion
2013-04

Outcome

Missed primary endpoint

registry analysis (superiority test); Clopidogrel Concentration of Higher Dose Aspirin Group vs Clopidogrel Concentration of Low Dose Aspirin Group; p = 0.66; Median Difference (Final Values) 0.05; t-test, 2 sided NCT01341964 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg —
Comparator Aspirin Small molecule 325 mg —
Subject Clopidogrel Small molecule 600 mg —

Indications

No indication recorded.